Shorted
Somnomed logo
SOM
Health Care Equipment & Services

Somnomed

Short interest
0.00%
0.00 pp 30d
as of 11 Aug 2026
Reported shorts
669
Shares on issue
219.768M

Somnomed (SOM) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
28 Sept

NAOS Asset Management Boosts Somnomed Limited Stake to 6.13% Following On-Market Share Purchase

Somnomed Limited (ASX:SOM) has been informed that NAOS Asset Management Pty Ltd along with its associated substantial holders have elevated their combined relevant interest in the company's ordinary shares to 6.13%, subsequent to an on-market acquisition executed on 25 September 2026. Key Points NAOS Substantial Holders' voting power in Somnomed rose from 5.10% to 6.13% of ordinary shares. An on-market purchase of 2,294,294 ordinary shares was finalized on 25 September 2026 for a total consid...

Continue reading
Kalkine
Neutral
4 Sept

SomnoMed Terminates 77,000 SOMAP Options Due to Unmet Conditions

SomnoMed Limited (ASX:SOM) has informed the ASX about the termination of 77,000 unquoted options following the expiration of a conditional right to securities, as the conditions tied to these options were either unmet or became impossible to fulfill. Key Points 77,000 SOMAP options (expiring 31 August 2027, exercise price $2.33) ceased on 4 September 2026 Termination resulted from the lapse of a conditional right due to unsatisfied or unfulfillable conditions No payment or consideration was m...

Continue reading
Kalkine
Positive
5 Aug

Growth Stocks: Why Is SomnoMed (ASX:SOM) Unaudited Annual Results Update in Focus?

Highlights unaudited annual results update is the immediate operational question for SomnoMed. The update is best assessed against the business model and stated priorities. The next reporting point will add evidence on execution. SomnoMed (ASX:SOM) is in focus this week after an announcement on unaudited annual results update, giving Australian readers a concrete new development to assess within the current market setting. The execution question This is a business-execution story. SomnoMed ha...

Continue reading
Kalkine
Neutral
27 July

SomnoMed Director Amrita Singh Blickstead Resigns, Discloses Final Shareholding and Options

SomnoMed Limited has submitted a Final Director's Interest Notice to the ASX following the resignation of director Amrita Singh Blickstead on 27 July 2026. The notice details her shareholding at the time of departure, including ordinary shares and options held in the dental device and sleep apnea treatment firm. This filing satisfies all regulatory disclosure requirements related to the director's exit. Key Points SomnoMed Limited (ASX: SOM), a medical device company focused on oral appliance...

Continue reading